Trafalgar International (GCAN) Other Accumulated Expenses (2017 - 2026)
Greater Cannabis Company (GCAN) posted quarterly Other Accumulated Expenses of $268600.0 for Q1 2026, up 3.31% year-over-year from $260000.0 in Q1 2025, and up 1.9% quarter-over-quarter from $263600.0 in Q4 2025.
Trafalgar International (GCAN) Other Accumulated Expenses (2017 - 2026) Analysis & Trends
Greater Cannabis Company's Other Accumulated Expenses history runs 9 years deep, the most recent figure standing at $268600.0 for Q1 2026.
- In Q1 2026, Other Accumulated Expenses rose 3.31% year-over-year to $268600.0; the TTM figure through Mar 2026 stood at $268600.0 (up 3.31% YoY), while the FY2025 annual figure was $263600.0, up 1.38% from the prior year.
- Other Accumulated Expenses for Q1 2026 stood at $268600.0, up from $263600.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $268600.0 in Q1 2026, with the low at $260000.0 in Q4 2022.
- The 5-year median for Other Accumulated Expenses is $260000.0 (2022), against an average of $260871.4.
- The sharpest annual moves came in 2023 and 2026: Other Accumulated Expenses changed 0.0% in 2023, then rose 3.31% in 2026.
- Greater Cannabis Company's Other Accumulated Expenses stood at $260000.0 in 2022, then changed by 0.0% to $260000.0 in 2023, then changed by 0.0% to $260000.0 in 2024, then advanced by 1.38% to $263600.0 in 2025, then rose by 1.9% to $268600.0 in 2026.
- Business Quant data shows GCAN's Other Accumulated Expenses at $268600.0 in Q1 2026, $263600.0 in Q4 2025, and $260000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 268,600.00 |
| Dec 31, 2025 | 263,600.00 |
| Sep 30, 2025 | 260,000.00 |
| Jun 30, 2025 | 260,000.00 |
| Mar 31, 2025 | 260,000.00 |
| Dec 31, 2024 | 260,000.00 |
| Sep 30, 2024 | 260,000.00 |
| Jun 30, 2024 | 260,000.00 |
| Mar 31, 2024 | 260,000.00 |
| Dec 31, 2023 | 260,000.00 |
| Sep 30, 2023 | 260,000.00 |
| Jun 30, 2023 | 260,000.00 |
| Mar 31, 2023 | 260,000.00 |
| Dec 31, 2022 | 260,000.00 |
| Jun 30, 2020 | 50,000.00 |
| Mar 31, 2020 | 50,000.00 |
| Dec 31, 2019 | 27,977.00 |
| Mar 31, 2018 | 91,305.00 |
| Dec 31, 2017 | 87,397.00 |